Effect of Spironolactone on Left Ventricular Mass and Aortic Stiffness in Early-Stage Chronic Kidney Disease: A Randomized Controlled Trial
- 4 August 2009
- journal article
- research article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 54 (6), 505-512
- https://doi.org/10.1016/j.jacc.2009.03.066
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- The Aggravating Mechanisms of Aldosterone on Kidney FibrosisJournal of the American Society of Nephrology, 2008
- Selective Mineralocorticoid Receptor Blocker Eplerenone Reduces Resistance Artery Stiffness in Hypertensive PatientsHypertension, 2008
- Aldosterone and Vascular InflammationHypertension, 2008
- Prevalence of Chronic Kidney Disease in the United StatesJAMA, 2007
- Long-Term Cardiac Effects of Adrenalectomy or Mineralocorticoid Antagonists in Patients With Primary AldosteronismHypertension, 2007
- Regional left ventricular function in individuals with mild to moderate renal insufficiency: The Multi-Ethnic Study of AtherosclerosisAmerican Heart Journal, 2007
- Stiffness of Capacitive and Conduit ArteriesHypertension, 2005
- Kidney Disease as a Risk Factor for Development of Cardiovascular DiseaseHypertension, 2003
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Aortic Pulse Wave Velocity as a Marker of Cardiovascular Risk in Hypertensive PatientsHypertension, 1999